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The successful surgical treatment of medically refractory epilepsy is based on one of three different principles: (1) elimination
of the epileptic focus, (2) interruption of the pathways of neural propagation, and (3) increasing the seizure threshold through
cerebral lesions or electrical stimulation. Temporal lobe epilepsy, being the most common focal epilepsy, may ultimately require
temporal lobectomy. This is a case report of a 36-year-old male with drug-resistant right mesial temporal lobe epilepsy who
failed to obtain seizure control after stereotactic radiosurgery to the seizure focus.
Complex-partial seizures occurred 6–7 times monthly, and consisted of a loss of awareness followed by involuntary move-
ments of the right arm. EEG/CC TV monitoring indicated a right mesial temporal lobe focus, which was corroborated by
decreased uptake in the right temporal lobe by FDG-PET and by MRI findings of right hippocampal sclerosis. Stereotactic
radiosurgery was performed with a 4MV linac, utilizing three isocenters with collimator sizes of 10, 10, and 7 mm respectively.
A dose of 1500 cGy (max dose 2535 cGy) was delivered in a single fraction to the patient’s right amygdala and hippocampus.
There were no acute complications. Following radiosurgery the patient’s seizures were improved in both frequency and in-
tensity for approximately 3 months. Antiepileptic medications were continued. Thereafter, seizures increased in both frequency
and intensity, occurring 10–20 times monthly. At 1 year post radiosurgery, standard right temporal lobectomy including amyg-
dalohippocampectomy was performed with subsequent resolution of complex-partial seizures. Histopathology of the resected
temporal lobe revealed hippocampal cell loss and fibrillary astrocytosis, consistent with hippocampal sclerosis. No radiation-
induced histopathologic changes were seen.
We conclude that low-dose radiosurgery doses temporarily changed the intensity and character of seizure activity, but actu-
ally increased seizure activity long-term. If radiosurgery is to be an effective alternative to temporal lobectomy for medically
intractable temporal lobe epilepsy, higher radiosurgery doses will be required. The toxicity and efficacy of higher-dose radio-
surgery is currently under investigation.
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INTRODCTION
The epilepsies have been classified into the ‘gener-
alized’ and ‘partial’ categories based on localization
and propagation. This classification not only helps pre-
dict which medical therapy is likely to be effective
but also helps predict responsiveness to invasive ther-
apy1. Standardized surgical techniques for epilepsy
date back to Penfield and Jasper2. Partial epilepsy
commonly originates in the temporal lobe. Since the
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discovery that the mesiobasal limbic structures play
an important role in the origin and maintenance of
most temporal lobe seizures, a common surgical treat-
ment for medically intractable temporal lobe epilepsy
is selective amygdalohippocampectomy employing a
microsurgical technique3. The concept of using ion-
izing radiation in the treatment of epilepsy was first
addressed in 19054. Since then a number of anec-
dotal and retrospective reports have described ben-
eficial effects of radiotherapy on seizure frequency
and intensity. The majority of these reports have been
serendipitous observations that seizure activity can de-
crease after radiation of low-grade gliomas and arte-
riovenous malformations5, 6, even if the irritant focus
failed to respond to treatment. More recently, stereo-
tactic radiosurgery has emerged as a method of treat-
ment for medically intractable mesial temporal lobe
epilepsy as an alternative to selective amygdalohip-
pocampectomy. Regis and colleagues reported results
on seven patients with drug-resistant seizures who un-
derwent 60Co radiosurgery. All seven has cessation of
seizures by 15 months post-treatment, and all but one
remain seizure-free after follow-up of 24–61 months7.
A follow-up report in 16 patients corroborates their
initial efficacy results8. In this case report we will dis-
cuss the use of a linac-based radiosurgery technique
on a patient with medically intractable mesial tempo-
ral lobe epilepsy enrolled in a pilot institutional trial
and give recommendations for further clinical studies.
CASE HISTORY AND METHODS
The patient is a 36-year-old right handed male with
a history of infantile febrile seizures which spon-
taneously resolved at the age of 4. Partial com-
plex seizures, sometimes with secondary generaliza-
tion, started following trauma to his occipital skull at
age 18. The current seizure episodes were refractory
to vigorous pharmacologic treatment, occurred 6–7
times monthly, and were initiated by a loss of aware-
ness followed by hitting or beating of his abdomen
with his right hand, stiffening of his left arm, and
occasional turning of his head to the right. Episodes
lasted 30–60 seconds, followed by a postictal pe-
riod of 1–2 hours. A variety of anti-epileptic drugs
and combinations were used before determining his
seizures were medically refractory, including pheny-
toin, carbamazepine, Phenobarbital, clonazepam, and
gabapentin.
Gadolinium-enhanced MRI using sagittal T1, axial
and coronal proton density and T2 images, as well
as axial T1 and coronal MP RAGE images showed
a focal area of asymmetric thinning and sclerosis
of the right amygdala and hippocampal parenchyma
with associated increased T2 signal (Fig. 1). The left
hippocampus appeared normal, as did the remaining
cerebral parenchyma. Of note, slight wasting of the
cerebellar folia was observed, consistent with chronic
phenytoin therapy. EEG from scalp and sphenoid elec-
trodes combined with closed-circuit TV monitoring
recorded eight complex partial seizures arising from
the right temporal region at the right sphenoid elec-
trode. In addition, right temporal slowing was ob-
served, consistent with focal cerebral dysfunction in
this region. 18F-fluorodeoxyglucose (FDG) positron
emission tomography showed decreased uptake in the
right temporal lobe compared to the left, particularly
mesially (asymmetry index of 20%). Cerebral angiog-
raphy using a digital subtraction technique showed no
evidence of aneurisms, arteriovenous malformations,
or evidence of fetal connections between the anterior
and posterior circulation.
Fig. 1: Axial magnetic resonance image of patient
pre-radiosurgery. Note right medial temporal lobe sclerosis
with increased T2 signal, typical of long-term epilepsy.
The patient elected to be enrolled on an IRB
approved institutional randomized trial comparing
stereotactic radiosurgery with standard temporal
lobectomy, and was randomized to radiosurgery af-
ter informed consent was obtained. Stereotactic ra-
diosurgery was performed using a 4MV linac (Varian
Clinac 4/100, Palo Alto, CA) using a Brown–Roberts–
Wells stereotactic head frame, Philips SRS Isocentric
subsystem, and X-Knifer 3.0 (Radionics, Burling-
ton, MA) planning software. Both CT and MRI imag-
ing were used to determine the target structures (right
amygdala and hippocampus) as well as sensitive non-
target structures (Fig. 2). The target region was treated
in a single fraction to a dose of 1500 cGy at the 57%
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isodose line (2535 cGy maximum) using three sepa-
rate isocenters using collimator diameters of either 7
or 10 mm (Fig. 3). The decision to use this isodose
line ensured no more than 900 cGy was delivered to
the brainstem. We used 960–990 arc degrees within
8–9 non-coplanar arcs for each isocenter.
Fig. 2: 3-Dimensional reconstruction of patient’s anatomy
during stereotactic radiosurgery using both CT and MRI,
showing amygdala and hippocampus (dark blue), brainstem
(yellow), optic chiasm (green), optic nerves (gold), and eyes
(green).
Fig. 3: Axial CT image with overlay of isodose distribution
using three separate isocenters with collimator diameters of
7, 10, and 10 mm respectively. The prescription isodose line
of 1500 cGy covered the target region (amygdala and
hippocampus) at 57% of maximum dose. Isodose lines for
1000 cGy and 800 cGy are also shown.
RESULTS
Following radiosurgery, the patient had no acute or
subacute complications. The patient was maintained
on double anti-seizure medications following treat-
ment. During the first 30 days he experienced no
seizures, and during months 2 and 3 he recorded a total
of four seizures. Seizures were milder, but otherwise
their character did not change following radiosurgery,
and after month 3 his episodes began to increase back
to baseline (approx. 6–8 monthly). After 3 months,
seizure frequency increased above pre-treatment lev-
els to 15–20 each month, and seizures became longer
and more severe. Post-irradiation MRI obtained at
6 months again showed unchanged cerebellar atrophy
and subtle asymmetry of the medical temporal lobes,
and no abnormal enhancement or edema to suggest ra-
diation injury.
The patient continued to be followed for 1 year with-
out significant intervention or change in seizure fre-
quency or intensity. The patient’s neurologic exam-
inations remained unchanged from his pre-treatment
status. EEG at 14 months showed continued right
centro-temporal slowing in the 2–4 Hz range, and
MRI at 12 months again showed no significant change.
It was, therefore, decided that radiosurgery treatment
had failed to improve seizure frequency, intensity, or
produce any radiographic evidence of necrosis. At the
recommendation of the epilepsy committee (epileptol-
ogist, neurosurgeon, and others) the patient underwent
right temporal craniotomy and standard right tem-
poral lobectomy. Intraoperative electrocorticography
using surface and depth electrodes were performed
which showed that all epileptiform activity was within
the hippocampus, which corroborated previous EEGs.
Thereafter, the parahippocampal gyrus, amygdala, and
2–2.5 cm of hippocampus and uncus were removed
along with 5.5 cm of lateral temporal cortex. Re-
peat electrocorticography showed residual epilepti-
form activity behind the line of the excision. Postop-
eratively he was continued on Tegretol and Neuron-
tin. Histopathology of the resected specimen revealed
hippocampal cell loss and fibrillary astrocytosis, con-
sistent with epilepsy-related sclerosis. No radiation-
induced histopathologic changes were seen (Fig. 4).
At initial 6-week follow-up, the patient had noted
no further complex-partial seizure activity, but he did
have residual auras. He has continued to be seen by the
epileptologist for 18 months on a regular basis and has
remained free of complex-partial seizures. However,
he continues to have isolated auras and he continues
on antiepileptic drugs.
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DISCUSSION
The reported yearly incidence of new onset epilepsy is
approximately 20–50 per 100 000 population and the
prevalence is between 2 and 10 per 1000 population9.
An extensive review of multiple large series of adult
patients with seizures reported that 67% were focal
(partial) in onset, 20% generalized, and 13% unclas-
sified10. It is worth emphasizing that all of the partial
epilepsies can become secondarily generalized, and
that the focal onset may be obscured. If localized ther-
apy is to be effective in controlling seizure activity, by
definition it must be in those patients who have the
partial variety. In addition, effective localized therapy
must eliminate the epileptic focus, interrupt the path-
ways of neural propagation, or increase the epilepto-
genic threshold through cerebral lesions or electrical
stimulation.
Fig. 4: Histopathology of resected temporal lobe specimen.
Neuronal cell loss with fibrillary astrocytosis (gliosis) are
commonly seen with epilepsy. The normal appearing
vasculature without significant fibrosis of the media and
adventitia indicate no significant radiation effect one year
after treatment. Perivascular edema is consistent with
enhancement seen on T2-weighted MRI images.
The clinical use of radiosurgery in the treatment
of medically refractory epilepsy has been derived co-
incidentally from beneficial effects of ionizing radi-
ation (brachytherapy, fractionated radiation therapy,
or radiosurgery) observed in patients with arteriove-
nous malformations and brain tumors experiencing
secondary seizures. Seizures often subside in these
patients even if the seizure focus resided outside the
mass lesion and received considerably less dose, and
before any radiographic evidence of response within
the target lesion11.
Considering published data, particularly from Eu-
ropean centers, showing the efficacy of moderate-
dose radiosurgery in controlling medically resistant
epilepsy, there are a number of possible explanations
why treatment failed in this particular case. The first
is that a radiation dose of 15 Gy to the periphery of
the target (25.35 Gy maximum dose) is insufficient to
either ablate tissue within the seizure focus or cause
enough neuronal damage to a large enough area to hin-
der propagation of electrical activity. Although previ-
ous reports using radiosurgery consistently document
doses as low as 10–20 Gy12 as effective in control-
ling seizures, histopathology of our patient’s resected
temporal lobe specimen showed no evidence of ra-
diation effect. We would therefore advocate the use
of doses greater than 2500 cGy in future patients. A
second possibility is that the epileptogenic zone may
not have been within the high-dose radiation volume
or extended beyond that volume. It has been reported
that the target point for radiosurgery using MRI or
CT-based treatment planning is unsuccessful in many
cases; the epileptogenic area is not located at the lesion
area or sclerosis, but around it. This stresses the impor-
tance of obtaining good electrophysiological localiza-
tion13. It may be that extracranial EEG was too impre-
cise to accurately target anatomy responsible for this
patient’s seizure genesis. This is in contrast to resec-
tive surgery, where in situ electrocorticographic local-
ization of the epileptogenic focus (or foci) is routinely
performed the moment before resection. In addition,
previous reports using radiosurgery have commonly
used large collimator diameters (20–35 mm), which
may provide assurance of including the focus14. This
volume of tissue is similar to what would be resected
during a standard temporal lobectomy. However, we
used only 7–10 mm collimators in a attempt to avoid
edema and brainstem injury. Dose–volume histogram
analysis of the patient’s radiosurgery treatment indi-
cate that the 1500 cGy volume encompassed 2.4 cm3.
This volume of tissue is somewhat smaller than would
typically be resected during selective amygdalohip-
pocampectomy, and therefore may be too small to
have adequately obliterated the entire neuronal path-
way for seizure propagation.
Until further scientifically controlled prospective
studies are available, the use of radiosurgery for med-
ically intractable seizures must be performed only in
controlled clinical settings. We have discontinued en-
rollment on this randomized trial, and are now utiliz-
ing selective amygdalohippocampectomy as our stan-
dard surgical procedure. We will be enrolling future
patients in a single arm pilot study to better determine
the optimal volumes and doses necessary for seizure
control. Patients that might benefit from enrollment
include those patients ineligible for surgery for med-
ical reasons, patients simply not wanting to consider
surgery despite being excellent candidates, or patients
who have symptomatic seizures secondarily produced
by mass-occupying lesions that require radiosurgery
as standard treatment (AVMs, gliomas, meningiomas,
etc.). We would advocate radiosurgery in this case
only after a clearly defined focus is determined by
MRI, FDG-PET, and electrocorticographic studies.
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Optimal doses appear to be greater than 2500 cGy and
radiation volumes should treat 25–30 mm of amyg-
dala and anterior hippocampus in order to treat tissue
volumes comparable to what is typically removed by
surgical amygdalohippocampectomy.
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